Additional file 1: Table S1. of Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program Peter Lee Judith Ross Birgitte Pedersen Primoz Kotnik John Germak Henrik Christesen 10.6084/m9.figshare.c.3619061_D1.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Noonan_syndrome_and_Turner_syndrome_patients_respond_similarly_to_4_years_growth-hormone_therapy_longitudinal_analysis_of_growth-hormone-na_ve_patients_enrolled_in_the_NordiNet_International_Outcome_Study_and_the_ANSWER_Progr/4387880 Estimated means (unadjusted) of HSDS for Noonan syndrome and Turner syndrome patients per year. Table S2. Estimated means (unadjusted) of ΔHSDS for Noonan syndrome and Turner syndrome patients from baseline. Table S3. Change in IGF-I SDS over time. (DOC 174 kb) 2015-09-08 05:00:00 Noonan syndrome Turner syndrome Human growth hormone